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AbstrACt
Objectives The aim of this study was to use the 
parametric g- formula to estimate the 19- year risk of 
myocardial infarction (MI) under hypothetical interventions 
on six cardiovascular risk factors.
Design and setting A populations- based cohort study 
with repeated measurements, the Tromsø Study.
Primary outcome measure Myocardial infarction.
Participants We estimated the relative and absolute 
risk reduction under feasible and intensive risk reduction 
strategies for smoking, physical activity, alcohol drinking, 
body mass index, total serum cholesterol and systolic 
blood pressure in 14 965 men and women with 19 years 
of follow- up (1994–2013).
results The estimated 19- year risk of MI under no 
intervention was 7.5% in individuals with baseline mean 
age 49.3 years (range 25–69). This risk was reduced 
by 30% (95% CI 19% to 39%) under joint feasible 
interventions on all risk factors, and 70% (60%, 78%) 
under a set of more intensive interventions. The most 
effective interventions were lowering of total cholesterol 
to 5.18 mmol/L and lowering of systolic blood pressure to 
120 mm Hg (33% and 37% lower MI risk, respectively). 
The absolute risk reductions were significantly larger in 
men, in older participants, in smokers and in those with 
low education.
Conclusion Modification of population levels of 
cardiovascular risk factors could have prevented close to 
one- third of the cases of MI in the municipality of Tromsø 
during 19 years of follow- up.
IntrODuCtIOn
The population burden of cardiovascular 
disease (CVD) differs between regions but 
remains the leading global cause of death. 
CVD accounted for more than 17.6 million 
deaths in 2016, a number that is expected to 
grow to more than 23.6 million by 2030.1 In 
Europe and the USA, CVD accounts for more 
than 30% of all deaths.1–3 The costs associated 
with CVD are estimated at €210 billion per 
year across the EU.2 Coronary heart disease 
(CHD) is the leading cause of death attrib-
utable to CVD, 44% in the USA in 20151 
and 34% in Norway in 2017.3 In the setting 
of ageing populations and adverse obesity 
trends,4 the burden of CVD represents a 
major global health challenge. Attention to 
the cardiovascular health of populations is 
therefore warranted to prevent or postpone 
disabilities, years of life lost and medical costs. 
Ideally, randomised clinical trials should be 
performed to address questions about the 
population impact of diverse CVD risk factor 
interventions. In practice, answers need to 
be inferred from population- based cohort 
studies. A methodological challenge is the 
treatment of time- dependent confounders 
that are effected by prior application of an 
intervention.5 For example, if the effect of 
long- term weight loss is of interest, prior 
blood cholesterol levels should be adjusted as 
a time- varying confounder, but future choles-
terol levels can be affected by weight loss. 
The most common adjustment method, that 
is, adding both weight loss and blood choles-
terol as time- varying covariates in a regres-
sion model, can lead to bias.6 7 We are aware 
strengths and limitations of this study
 ► The main body of knowledge showing the effect of 
interventions of cardiovascular risk factors on myo-
cardial infarction are from population- based cohort 
studies using traditional methods.
 ► The g- formula handles joint hypothetical interven-
tions on multiple risk factors.
 ► The g- formula appropriately adjusts for time- 
dependent confounding affected by prior exposures.
 ► The results are valid only in the absence of model 
mis- specification, unmeasured and residual con-
founding and measurement errors.
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of only two US studies8–10 that have used Robins’ g- for-
mula7 to overcome this bias when estimating the effect 
of interventions on coronary heart disease. Our aim was 
therefore to use the g- formula to estimate the effect of 
various hypothetical interventions on the risk of incident 
myocardial infarction (MI) in the Tromsø Study in men 
and women aged 25–69 years and with repeated measure-
ments over 19 years of follow- up.
MAterIAls AnD MethODs
study population
The population- based, prospective Tromsø Study consists 
of seven surveys referred to as Tromsø 1–7, conducted in 
the municipality of Tromsø, Norway from 1974 to 2016.11 
The baseline population for this study was Tromsø 4 in 
1994–1995, where all men and women aged ≥25 years 
living in the municipality were invited and 72% partici-
pated (n=27 158). Eligible for the present study were 16 
792 subjects in Tromsø 4 who also had prebaseline data 
from one of the previous surveys Tromsø 2 (1979–1980) 
or Tromsø 3 (1986–1987). The following participants 
were excluded from analyses: did not consent to medical 
research (n=68), were pregnant (n=283), had incomplete 
covariate history prebaseline (n=833) or at baseline even 
after carrying data one survey forward (n=328), had prev-
alent MI (n=305) or had moved out of the municipality 
prior to their date of examination (n=10). Thus, n=14 
965 men and women were included. All participants gave 
written informed consent.
Patient and public involvement
Patients or the public were not involved in the design of 
the study.
Measurements
Each survey used a standardised protocol of nearly 
identical methods including physical examination and 
blood sampling. Information about smoking, physical 
activity, alcohol consumption, diabetes, education and 
pregnancy were collected by questionnaire data (online 
supplementary material). Blood pressure was measured 
with an automated device in Tromsø 3–Tromsø 6 and 
with a standard stethoscope and mercury sphygmoma-
nometer in Tromsø 2 (online supplementary material). 
Non- fasting blood samples were analysed by standard 
methods at the Department of Laboratory Medicine, 
University Hospital of Northern Norway. Smoking status 
was defined as either non- smoker or number of cigarettes 
smoked per day among daily smokers (online supplemen-
tary material). Leisure time physical activity was defined 
from different questions in the surveys.12 The number of 
minutes per week of light and hard activity was estimated, 
and physical activity was divided into three levels: inactive 
being no light or hard physical activity per week, suffi-
ciently active being ≥150 min/week of moderate activity 
or ≥75 min/week of vigorous activity, insufficiently active 
being all other levels of activity. Alcohol consumption was 
harmonised into two levels: 1=never or rarely, 2=all others 
(online supplementary material).
Identification and validation of incident MI
Incident cases of MI were recorded from the date of enrol-
ment in 1994–1995 to the end of follow- up, 31 December 
2013. MIs were identified by linkage to the diagnosis 
registries at the University Hospital of North Norway and 
the National Causes of Death Registry. We used modified 
WHO MONICA/MORGAM criteria for MI and an inde-
pendent endpoint committee adjudicated hospitalised 
and out- of hospital events (online supplementary mate-
rials). Dates of emigration were obtained from the Popu-
lation Registry of Norway.
Follow-up
Participants who were still under follow- up for MI and 
attended the later surveys in 2001 (Tromsø 5, n=4748) 
and/or in 2007–2008 (Tromsø 6, n=6833) had their risk 
factor values updated at the date of their examination. 
If a covariate was missing, we carried data over from 
the previous survey. If a covariate was missing for two 
consecutive surveys, we censored the participant on 
31 December 2008 after carrying the data over for one 
survey. Among censored subjects (n=6106), 1522 moved 
out of the municipality prior to end of follow- up, 510 
attended at least one follow- up examination but were 
missing some covariate values, and 4074 did not attend 
a repeat follow- up examination. The majority (80%) of 
the latter were not invited to a repeat follow- up exam-
ination due to age restrictions or as a result of being 
randomly excluded from the sampling. In total, 58% 
attended at least one repeat follow- up examination. 
This number increased to 88% restricted to those in 
the prespecified age groups that we know would be 
invited to later surveys (mostly those aged 50–69 years 
at baseline).
risk reduction strategies
We considered six feasible and six intensive hypothetical 
interventions and their combination. The feasible inter-
ventions were: (1) 20% of daily smokers quit smoking, (2) 
20% move to sufficient physical activity, (3) 20% of non- 
drinkers become moderate drinkers of alcohol, (4) lower 
body mass index (BMI) to 25 kg/m2 or lose 10% BMI 
if BMI ≥27.78 kg/m2, (5) lower total cholesterol to 6.22 
mmol/L (240 mg/dL), (6) lower systolic blood pressure 
to 140 mm Hg. The intensive interventions were: (1) all 
daily smokers quit smoking, (2) all move to sufficient phys-
ical activity, (3) all become moderate drinkers of alcohol, 
(4) lower BMI to 25 kg/m2, (5) lower total cholesterol 
to 5.18 mmol/L (200 mg/dL), (6) lower systolic blood 
pressure to 120 mm Hg. The interventions were based 
on evidence from randomised trials and clinical guide-
lines.13–15 For both the feasible and intensive interven-
tions, we combined interventions 1–4 and interventions 
1–6. All interventions were applied at each time point.
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statistical methods
We used the parametric g- formula to estimate the 
19- year risks of MI under the selected interventions.5 9 
The g- formula is a generalisation of standardisation for 
time- varying exposures and confounders. A simplified 
description of the estimation process is as follows: first, 
we fit regression models on the entire study population 
to predict each time- varying covariate, to predict non- MI 
death and to predict MI. Then we use the fitted regression 
models to simulate MI for each time period under each 
intervention in five steps: (1) use the observed values of 
covariates at baseline; (2) predict the joint distribution 
of the time- varying covariates at the next time- point; (3) 
‘intervene’ by setting the values of covariates to the values 
determined by the hypothetical intervention; (4) predict 
the probability of MI and non- MI death using these new 
values; (5) repeat steps (2) through (4) for each time 
period and estimate the population risk as the average of 
the subject specific risks. To examine the validity of our 
parametric models, we compared the observed means of 
the time- varying covariates, risk of death and myocardial 
infarction with those predicted by the models. We used 
non- parametric bootstrapping with 500 samples and 
defined the 2.5 and the 97.5 percentile as the 95% confi-
dence limits.
The time- varying covariates used in the regression 
models were fitted in the following order: number of 
cigarettes per day, physical activity, alcohol consumption, 
BMI, diabetes mellitus, systolic blood pressure, serum total 
cholesterol and serum high- density lipoprotein choles-
terol. In addition, the following variables were included 
as possible confounders: age, sex, time period, education, 
marital status, physical activity at work, prebaseline values 
of all time- varying covariates and the previous values of 
all time- varying covariates. Online supplementary table 1 
shows the functional form of all independent variables. 
The estimated 19- year MI risk under each intervention 
was compared with the risk under no intervention as 
population risk ratios and population risk differences. We 
also present the cumulative and average per cent inter-
vened on in a given time period. To examine the validity 
of our parametric models, we compared the observed 
means of the time- varying confounders, risk of death and 
CHD with those predicted by the models. Model assump-
tions in the prediction of each time- dependent contin-
uous variable were performed by residual analyses.
We assessed effect modification by conducting the anal-
ysis for the combined interventions in subgroups defined 
at baseline by sex, age (threshold of 55 years at baseline), 
daily smoking (yes/no), sufficient physical activity (yes/
no) and university level education (yes/no). Test of 
heterogeneity between groups were performed using a 
standard z- test.
We performed sensitivity analyses in which we (1) 
changed the ordering of the time- varying covariates when 
we predicted each covariate, (2) used multiple imputation 
to account for missing covariate values at baseline and 
prebaseline. For the latter, we used multiple imputation 
by fully conditional specification with 10 burn- in iter-
ations and 10 imputed datasets. Imputation methods 
for continuous variables, categorical with >2 levels, and 
binary variables were linear regression, discriminant func-
tion and logistic regression, respectively.
Cox proportional hazard regression was used to estimate 
HRs of incident MI for all six considered intervention 
variables. Values were updated in 2001 and 2007–2008, 
and HRs were adjusted for the intervention variables and 
for age, sex, education, high- density lipoprotein choles-
terol, diabetes mellitus, marital status and work time phys-
ical activity. All statistical analyses were performed using 
SAS software V.9.4 (SAS Institute). The SAS macro and its 
documentation are available online (http://www. hsph. 
harvard. edu/ causal/ software).
results
Table 1 shows baseline characteristics of 14 965 men and 
women aged 25–69 years. During 19 years of follow- up, 
there were 963 cases of MI and 1176 deaths. The simulated 
19- year MI risk was 7.5% compared with the observed MI 
risk of 7.6%. The mean difference in observed versus 
simulated values for the time- varying covariates were 
small and indicated a satisfactory fit of the model under 
the null (online supplementary figure 1).
Among the six single feasible hypothetical interven-
tions shown (table 2), lowering total serum cholesterol 
to 6.22 mmol/L and lowering systolic blood pressure to 
140 mm Hg had the strongest proportional impact on MI 
risk. The population risk ratio for cholesterol was 0.87 
(95% CI 0.81 to 0.94) and 0.89 (0.82 to 0.96) for systolic 
blood pressure. Among BMI and the three lifestyle strat-
egies, only smoking cessation was significantly associated 
with reduced MI risk, with a population risk ratio 0.95 
(0.94 to 0.97). The joint intervention on smoking, phys-
ical activity, alcohol, and BMI was associated with 10% 
(2% to 16%) reduced MI risk by. The combination of all 
six interventions was associated with 30% (19% to 39%) 
reduced MI risk.
More intensive strategies were associated with stronger 
impact on MI risk reduction than feasible strategies 
(table 3). The combination of strategies on smoking, 
physical activity, alcohol intake and BMI was associated 
with 25% (12% to 36%) reduced MI risk. Adding serum 
cholesterol and systolic blood pressure was estimated to 
reduce MI risk by 70% (60% to 78%).
Online supplementary table 2 show HRs of associations 
between the six intervention variables and MI as esti-
mated by a conventional Cox model. All variables except 
for physical activity were significantly associated with MI.
The average per cent intervened on were 58% and 
71%, respectively, for the joint feasible and intensive 
intervention on smoking, physical activity, alcohol intake 
and BMI, and increased to 77% and 93% when adding 
risk factor control on serum cholesterol and systolic 
blood pressure (tables 2 and 3). Online supplementary 
table 3 shows hypothetical descriptive characteristics of 
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Number 14 965 4748 6833
Men, % 49.6 (7418) 45.4 (2154) 47.2 (3224)
Age, years 46.3 (10.2) 60.4 (9.4) 61.0 (9.5)
Body mass 
index, kg/m2












1.5 (0.4) 1.5 (0.4) 1.5 (0.4)
Daily smoking, 
%
  Non- smoker 29.4 (4383) 30.3 (1416) 31.6 (2129)
  Previous 
smoker
31.7 (4730) 40.9 (1916) 50.1 (3376)
  1–4 
cigarettes/
day
2.5 (367) 1.9 (90) 1.2 (84)
  5–14 
cigarettes/
day
22.9 (3414) 19.0 (891) 12.0 (806)
  15–24 
cigarettes/
day
11.8 (1761) 7.2 (339) 4.7 (320)
  ≥25 
cigarettes/
day




  Inactive 7.2 (1080) 4.9 (221) 4.9 (332)
  Insufficiently 
active
40.5 (6059) 37.5 (1696) 53.5 (3596)
  Sufficiently 
active
52.3 (7816) 57.6 (2607) 41.6 (2793)
Alcohol intake‡, 
% never or 
rarely
29.7 (4411) 25.6 (1043) 32.8 (2210)
Diabetes, % 1.1 (167) 3.1 (146) 5.2 (351)
Education
  ≤10 years of 
schooling
34.2 (5100) 47.3 (2176) 32.6 (2206)
  High school 
diploma
37.9 (5660) 27.8 (1278) 35.8 (2422)
  College or 
university <4 
years








  College or 
university≥4 
years
12.9 (1918) 11.7 (537) 14.9 (1008)
*Values are mean (SD) or per cent (number).
†Inactive = No minutes of light or hard physical activity per 
week. Sufficiently active ≥150 min/week with light activity or ≥75 
min/week with hard activity.
‡Alcohol intake=never or less than one unit per month.
HDL, high- density lipoprotein.
Table 1 Continued
the population after feasible and intensive intervention 
have been applied to each risk factor at each survey.
On the risk ratio scale, the effect of the joint inten-
sive interventions of all six risk factors was significantly 
stronger in younger individuals compared with older 
individuals (table 4). No other subgroup comparison 
achieved nominal statistical significance on the test 
of heterogeneity. On the additive scale, a significant 
subgroup difference in absolute risk between no interven-
tion and joint intensive interventions of all six risk factors 
were observed between all subgroups, except for leisure 
time physical activity. The subgroup with the highest esti-
mated MI risk had the highest reduction in absolute risk, 
but these subgroups also had the highest intervention per 
cent as reflected in the average per cent intervened on.
When using multiple imputation at baseline or 
prebaseline, the number of participants increased 
by 7% and the number of MIs by 5%. The majority of 
missing values was observed for baseline physical activity 
at work (22% missing). Prebaseline alcohol consump-
tion had 5% missing values. All other variables had less 
than 1% missing. The population risk ratios for the joint 
feasible interventions observed in the sensitivity analyses 
were identical compared with the analyses presented in 
table 2 and almost identical for the intensive interven-
tions presented in table 3 (online supplementary table 
4). When we changed the ordering of the time- varying 
covariates when fitting the regression models, the risk 
estimates did not change appreciably (online supplemen-
tary tables 5 and 6).
DIsCussIOn
We estimated that 30% of incident MI cases could have 
been prevented during 19 years of follow- up under a joint 
combination of six feasible risk reduction strategies of 
quitting smoking, increasing physical activity, moderate 
alcohol intake, weight loss and lowering serum choles-
terol and blood pressure. Under more intensive interven-
tions 70% of MI cases could have been prevented. The 
absolute risk reductions were significantly larger among 
men, smokers, those who did not have a college degree 
and those who were 55 years of age or older.
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Table 2 Risk of myocardial infarction under feasible hypothetical interventions.* The Tromsø study 1994–2008
No.












0 Natural course, no 
intervention†
7.48 (6.86 to 7.87) 1 0 0 0
1 20% of smokers quit smoking 7.10 (6.56 to 7.55) 0.95 (0.94 to 0.98) −0.38 (−0.43 to −0.18) 17 6
2 20% move to sufficient 
physical activity¶
7.32 (6.74 to 7.81) 0.98 (0.97 to 1.01) −0.15 (−0.24 to 0.06) 25 9
3 20% of non- drinkers become 
moderate drinkers of alcohol
7.33 (6.73 to 7.73) 0.98 (0.97 to 1.00) −0.15 (−0.25 to −0.01) 16 5
4 Lower BMI to 25 kg/m2 or lose 
10% BMI if BMI≥27.78 kg/m2
7.28 (6.44 to 7.89) 0.97 (0.91 to 1.05) −0.20 (−0.65 to 0.35) 67 49
5 Lower TC to <6.22 mmol/L 
(240 mg/dL)
6.53 (5.78 to 7.05) 0.87 (0.81 to 0.94) −0.95 (−1.41 to −0.43) 59 33
6 Lower SBP to <140 mm Hg 6.65 (6.00 to 7.27) 0.89 (0.82 to 0.96) −0.83 (−1.28 to −0.29) 55 33
7 Joint intervention 1–4 6.72 (6.00 to 7.32) 0.90 (0.84 to 0.98) −0.76 (−1.21 to −0.16) 82 58
8 Joint intervention 1–6 5.21 (4.40 to 6.04) 0.70 (0.61 to 0.81) −2.26 (−2.84 to −1.44) 94 77
*Estimated using the parametric g- formula with fixed covariates: age, sex, education, former smoking, marital status and work time physical activity; 
and time- varying covariates: smoking, physical activity, alcohol use, BMI, SBP, total cholesterol, high- density lipoprotein cholesterol and diabetes 
mellitus.
†Observed risk 7.64%.
‡The percentage of the population intervened on in at least one of the 6- year periods.
§Average per cent of the population intervened on in a given 6- year period.
¶Sufficient leisure time physical activity was defined as ≥150 min/week with light activity or ≥75 min/week with hard activity.
BMI, body mass index; MI, myocardial infarction; SBP, systolic blood pressure; TC, total serum cholesterol.
Table 3 Risk of myocardial infarction under intensive hypothetical interventions.* The Tromsø study 1994–2008
No.












0 Natural course, no 
intervention†
7.48 (6.86 to 7.87) 1 0 0 0
1 All smokers quit smoking 6.50 (5.90 to 6.94) 0.87 (0.83 to 0.92) −0.98 (−1.30 to −0.61) 44 19
2 All perform sufficient physical 
activity¶
7.13 (6.31 to 7.78) 0.95 (0.89 to 1.02) −0.35 (−0.79 to 0.14) 60 26
3 All become moderate drinkers 
of alcohol
6.99 (6.37 to 7.49) 0.93 (0.89 to 0.99) −0.49 (−0.80 to −0.09) 39 16
4 Lower BMI to <25 kg/m2 7.16 (6.24 to 8.02) 0.96 (0.88 to 1.07) −0.32 (−0.91 to 0.51) 67 48
5 Lower TC to <5.18 mmol/L 
(200 mg/dL)
5.02 (4.04 to 5.84) 0.67 (0.56 to 0.79) −2.46 (−3.24 to −1.55) 88 59
6 Lower SBP to 120 mm Hg 4.73 (3.75 to 5.68) 0.63 (0.52 to 0.77) −2.74 (−3.52 to −1.71) 91 66
7 Joint intervention 1–4 5.59 (4.66 to 6.49) 0.75 (0.64 to 0.88) −1.89 (−2.61 to −0.92) 95 71
8 Joint intervention 1–6 2.23 (1.59 to 2.94) 0.30 (0.22 to 0.40) −5.24 (−5.88 to −4.26) 100 93
*Estimated using the parametric g- formula with fixed covariates: age, sex, education, former smoking, marital status and work time physical activity; 
and time- varying covariates: smoking, physical activity, alcohol use, BMI, SBP, total cholesterol, high- density lipoprotein cholesterol and diabetes 
mellitus.
†Observed risk 7.64%.
‡The percentage of the population intervened on in at least one of the 6- year periods.
§Average per cent of the population intervened on in a given 6- year period.
¶Sufficient leisure time physical activity was defined as ≥150 min/week with light activity or≥75 min/week with hard activity.
BMI, body mass index; MI, myocardial infarction; SBP, systolic blood pressure; TC, total serum cholesterol.
The strengths of this study are the population based, 
prospective design with high participation proportion, 
the high sensitivity of event ascertainment, the use of 
adjudicated first- ever MI at the only local hospital, the 
inclusion of both hospitalised and out- of- hospital events 
and the standardised and repeated update of CVD risk 
factors. Also, the use of the parametric g- formula adjusts 
for time- varying confounding affected by prior exposures 
that enables simulation of long- term joint interventions on 
lifestyle and metabolic risk factors. Online supplementary 
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Table 4 Risk of myocardial infarction under intensive hypothetical interventions in subgroups at baseline.* The Tromsø study 
1994–2008





Men‡ Women§ Men‡ Women§ Men Women
Lifestyle change¶ 0.80 (0.67 to 0.94) 0.63 (0.43 to 0.88) 0.20 −2.19 (−3.58 to −0.73) −1.39 (−2.25 to −0.47) 0.35 74 68
Lifestyle change 
and risk factor 
control**
0.32 (0.22 to 0.45) 0.29 (0.13 to 0.48) 0.78 −7.41 (−8.73 to −5.93) −2.70 (−3.50 to −1.92) <0.001 94 92
Baseline age, years Baseline age, years
< 55†† ≥ 55‡‡ < 55†† ≥ 55‡‡ <55 ≥55
Lifestyle change¶ 0.72 (0.55 to 0.91) 0.81 (0.66 to 0.97) 0.46 −1.34 (−2.14 to −0.39) −3.11 (−5.52 to −0.55) 0.19 69 79
Lifestyle change 
and risk factor 
control**
0.19 (0.11 to 0.28) 0.54 (0.35 to 0.77) 0.002 −3.90 (−4.32 to −3.24) −7.56 (−10.6 to −3.67) 0.04 91 98
Daily smoking at baseline Daily smoking at baseline
No§§ Yes¶¶ No§§ Yes¶¶ No Yes
Lifestyle change¶ 0.87 (0.72 to 1.06) 0.67 (0.52 to 0.85) 0.10 −0.81 (−1.64 to 0.35) −3.06 (−4.51 to −1.43) 0.02 66 90
Lifestyle change 
and risk factor 
control**
0.34 (0.21 to 0.50) 0.26 (0.16 to 0.40) 0.42 −3.97 (−4.93 to −2.98) −6.90 (−8.16 to −5.39) <0.001 92 97
Baseline leisure time physical active Baseline leisure time physical active
Sufficient*** Inactive/insufficient††† Sufficient*** Inactive/insufficient††† Sufficient Inactive/ 
insufficient
Lifestyle change¶ 0.79 (0.67 to 0.95) 0.69 (0.49 to 0.92) 0.44 −1.51 (−2.34 to −0.38) −2.43 (−4.13 to −0.62) 0.36 64 91
Lifestyle change 
and risk factor 
control**
0.30 (0.19 to 0.46) 0.28 (0.16 to 0.44) 0.83 −4.94 (−5.82 to −3.70) −5.72 (−6.91 to −4.40) 0.36 91 98
Baseline education at university/college level Baseline education at university/college level
No‡‡‡ Yes§§§ No‡‡‡ Yes§§§ No Yes
Lifestyle change¶ 0.74 (0.63 to 0.87) 0.79 (0.57 to 1.06) 0.72 −2.18 (−3.09 to −1.07) −1.04 (−2.13 to 0.27) 0.16 74 61
Lifestyle change 
and risk factor 
control**
0.32 (0.23 to 0.44) 0.22 (0.10 to 0.42) 0.32 −5.75 (−6.63 to −4.56) −3.85 (−4.72 to −2.56) 0.01 94 89
*Estimated using the parametric g- formula with fixed covariates: age, education, former smoking, marital status and work time physical activity; and time- varying 
covariates: smoking, physical activity, alcohol use, BMI, SBP, total cholesterol, high- density lipoprotein cholesterol and diabetes mellitus.
†Test for heterogeneity between the groups.
‡The 19- year risk of MI under no intervention was 10.9% (95% CI; 10.0, 11.8).
§The 19- year risk of MI under no intervention was 3.79% (95% CI; 3.33, 4.35).
¶All smokers quit smoking, all perform sufficient leisure- time physical activity defined as ≥150 minutes per week with light activity or ≥75 minutes per week with hard 
activity, all become moderate drinkers of alcohol, lower BMI to < 25 kg/m2.
**Lifestyle change + lower TC to < 5.18 mmol/l (200mg/dL), lower SBP to < 120 mmHg.
††The 19- year risk of MI under no intervention was 4.81% (95% CI; 4.21, 5.23).
‡‡The 19- year risk of MI under no intervention was 16.6% (95% CI; 15.2, 17.8).
§§The 19- year risk of MI under no intervention was 6.04% (95% CI 5.43 to 6.58).
¶¶The 19- year risk of MI under no intervention was 9.26% (95% CI 8.39 to 10.1).
***The 19- year risk of MI under no intervention was 7.08% (95% CI 6.20 to 7.59).
†††The 19- year risk of MI under no intervention was 7.97% (95% CI 7.15 to 8.68).
‡‡‡The 19 year risk of MI under no intervention was 8.50% (95% CI; 7.76 to 9.05).
§§§The 19- year risk of MI under no intervention was 4.95% (95% CI 4.05 to 5.68).
BMI, body mass index; MI, myocardial infarction; PRD, population risk difference; SBP, systolic blood pressure; TC, total serum cholesterol.
figure 2 is an example of a directed acyclic graph showing 
time‐dependent confounding with confounder (BMI) 
affected by prior exposure (physical activity).
Like other cohort studies, our results are valid only in 
the absence of model misspecification, unmeasured and 
residual confounding, and measurement errors. A theo-
retical limitation of the parametric g- formula is the g- null 
paradox, which implies it can be essentially impossible to 
correctly specify the needed parametric models under 
the causal null hypothesis. One way of avoiding the g- null 
paradox is to only consider interventions for which we do 
not a priori believe that the null is true. Furthermore, the 
similarity between the observed and estimated risk under 
no intervention supports the absence of model misspeci-
fication under the null. When the per cent intervened on 
in each cycle approach 100%, the estimated effects are 
strongly model dependent and prone to model misspec-
ification. The highest average per cent intervened on 
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were for intensive interventions on total cholesterol and 
blood pressure, 59% and 66%, respectively. Although 
we adjusted for many potential confounders, we lacked 
information on diet, which may have led to unmeasured 
confounding. Some degree of bias from measurement 
error is to be expected, especially for the self- reported life-
style variables. The questionnaires used to assess alcohol 
consumption and physical activity were not consistent 
across surveys, which limited the analyses of alcohol use 
to a binary indicator. Another limitation is that 42% of 
the total cohort only attended the prebaseline and base-
line visit. In separate analyses, we used the g- formula for 
participants in the prespecified age groups that we know 
would be invited to later surveys. These were mostly 
participants with baseline age≥50 years, and 88% had 
at least one repeat visit. The risk ratio for the combined 
feasible intervention in this group was weaker compared 
with the total cohort, 0.81 versus 0.70, whereas the risk 
difference was slightly higher −2.44% versus −2.26%. As 
risk ratios for the MI effect of classical risk factors tend to 
decrease with age, these results do not indicate a bias for 
the total cohort.
Another g- formula assumption is consistency. Inter-
ventions should be well defined to perform meaningful 
causal inference. For example, the effect on MI of an 
intervention to lower BMI by 10% may be different 
depending on the degree of calorie restriction imposed, 
the foods allowed in the required diet and the level of 
increased physical activity. If the effect of BMI reduction 
on MI depend on the imposed method of weight reduc-
tion, it is unclear what the counterfactual quantity one 
hopes the g- formula to estimate.8
Two previous studies of cohorts in the USA have used 
the parametric g- formula to assess the potential impact 
that similar risk factor interventions would have had on 
coronary heart disease risk.8–10 However, the risk esti-
mates may not be fully comparable because of different 
risk factor distributions, different intensities of the risk 
reduction strategies and because of different question-
naires for assessing lifestyle. Results using g- formula are 
strongly dependent on baseline exposures: for example, 
lower prevalence of smoking in one study results in 
weaker risk ratios for quitting compared with a study with 
higher smoking prevalence. The Framingham Offspring 
Study presented risk estimates for joint interventions of 
smoking, alcohol and BMI that are comparable to our 
results, especially in men.10 The study also showed a strong 
effect of low- density lipoprotein cholesterol intervention 
that qualitatively agrees with our effect of total cholesterol 
intervention. Similar analyses using data from the Nurses’ 
Health Study showed beneficial effects of strategies on 
the risk of CHD for smoking, exercise and alcohol use in 
women that were somewhat stronger than ours but showed 
a non- significant effect for BMI comparable to our study.9 
Another g- formula analysis using data from the Nurses’ 
Health Study concluded that weight loss among over-
weight or obese women did not reduce the risk of death 
or CHD, while adjusting for unmeasured confounding by 
undiagnosed disease at baseline.8 Although a beneficial 
effect of weight loss on CHD have not been shown, such 
an effect cannot be ruled out as these null results may 
be due to unmeasured confounding, model misspecifica-
tion, measurement error or insufficient statistical power.
Several studies have shown that alcohol intake is causally 
related to lower risk of CHD.16 17 The effect of alcohol on 
high- density lipoprotein and fibrinogen levels accounts 
for the majority of the reduction in risk,16 but the inhi-
bition of platelet activation and anti- inflammatory effects 
could also play a role. Still, the mechanisms by which 
alcohol exerts its protective effect on the cardiovascular 
system are very complex and not completely understood. 
It is worth noting that the American Heart Association 
recommend that moderation is key, if you do not drink 
already, do not start.
Several studies have used more conventional statis-
tical methods to assess the burden of CVD attributed to 
multiple risk factors or the preventive effect associated 
with a combination of favourable levels of risk factors.18–21 
These estimates cannot be directly compared with the 
present results as they require additional assumptions. 
A previous analysis of the Tromsø Study showed that a 
moderate shift in a composite health metric score that 
included lifestyle variables used here except for alcohol 
intake19 could reduce MI risk by 14% in men and 16% in 
women.
From 1995 to 2010, age- adjusted and sex- adjusted inci-
dence of MI in the Tromsø Study decreased by 3% per 
year.22 Sixty- six per cent of the decline could be explained 
by favourable time trends in coronary risk factors, most 
notably in total cholesterol, blood pressure and daily 
smoking. An increase in the proportion of overweight/
obesity from 55% to 63% negated the MI decline. Despite 
a large increase in lipid- lowering drug use between 1994–
1995 and 2015–2016, only 21%–28% of the decline in 
total cholesterol in the Tromsø Study could be explained 
by drug use.23 These results indicate that population- wide 
changes in risk factor levels have a large potential for 
reducing the MI incidence.
COnClusIOn
Modification of cardiovascular risk factors by hypothetical 
interventions consistent with randomised trial evidence 
and clinical guidelines forecast notable reductions in 
the population burden of MI. We have shown that under 
six feasible intervention scenarios on cardiovascular risk 
factors, 30% of the MI events that occurred during 19 
years of follow- up in the Tromsø study population could 
have been prevented. The most effective hypothetical 
interventions were lowering of blood pressure and serum 
cholesterol, followed by smoking cessation. Although 
interventions were more effective on a relative scale in 
younger individuals (baseline age<55 years), the absolute 
risk reductions were significantly larger among individ-
uals ≥55 years of age as well as in men, smokers and in 
those who did not have a college degree.
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